A Novel and Reproducible Urinary Diagnostic Framework Reduces Health Care and Antibiotic Utilization for Urinary Tract Infections - Scorecard - MDSpire

A Novel and Reproducible Urinary Diagnostic Framework Reduces Health Care and Antibiotic Utilization for Urinary Tract Infections

  • By

  • Kendall Kling

  • Teresa Zembower

  • W Justin Moore

  • Janna Williams

  • Amanda Vo

  • Stephanie Colbert

  • Anthony Schaeffer

  • May 15, 2025

  • 0 min

Share

Clinical Scorecard: An Innovative and Consistent Urinary Diagnostic Approach Decreases Antibiotic Use and Health Care Demands for Urinary Tract Infections

At a Glance

CategoryDetail
ConditionComplex urinary tract infections (UTIs), including complicated and uncomplicated cases
Key MechanismsStandardized urinary infection diagnostic framework (UDF) using anatomic and diagnostic categorization, interdisciplinary evaluation, and targeted treatment
Target PopulationPatients referred for complex UTIs, including those with recurrent infections, urinary bacterial persistence, and noninfectious urinary syndromes
Care SettingInterdisciplinary clinic involving infectious diseases specialists, urologists, and antimicrobial stewardship pharmacists

Key Highlights

  • Use of a standardized UDF reduced hospitalizations, emergency department/urgent care visits, and antibiotic use for UTIs.
  • 32% of patients referred for UTIs were found to have noninfectious syndromes, highlighting the importance of accurate diagnosis.
  • Multimodal management including source control and antimicrobial suppression achieved 95% infection control in patients with urinary bacterial persistence.

Guideline-Based Recommendations

Diagnosis

  • Classify UTIs as complicated or uncomplicated based on urinary tract anatomy and function.
  • Use specific symptom and culture criteria; exclude nonspecific symptoms such as suprapubic pain, altered mental status, fatigue, incontinence, cloudy or foul-smelling urine as reliable UTI indicators.
  • Perform postvoid residual urine measurement routinely.
  • Identify bacterial persistence and consider urologic evaluation for nidus detection.

Management

  • Treat patients according to diagnostic categorization with supportive care, targeted UTI treatment, prevention therapies, and surgery when appropriate.
  • Apply antimicrobial stewardship principles, including selecting agents for multidrug-resistant organisms and optimizing perioperative antibiotic use.
  • Implement multimodal approaches for bacterial persistence, including source removal or antimicrobial suppression.

Monitoring & Follow-up

  • Track infection resolution, recurrence, and prevention therapy effectiveness.
  • Monitor antibiotic exposure and healthcare utilization pre- and post-intervention.
  • Follow patients longitudinally to assess UTI-free status and need for further intervention.

Risks

  • Avoid overtreatment of asymptomatic bacteriuria except in pregnancy, pre-urologic procedures involving mucosal disruption, or early post-kidney transplant period.
  • Recognize that misattribution of nonspecific urinary symptoms to UTI can lead to unnecessary antibiotic use and contribute to multidrug-resistant organism development.

Patient & Prescribing Data

216 patients referred for complex UTIs, including recurrent infections and bacterial persistence cases

Following implementation of the UDF, patients experienced significantly fewer hospitalizations, emergency visits, and antibiotic courses, with 69% UTI-free rate at mean 4.6 months follow-up among those on prevention therapy.

Clinical Best Practices

  • Utilize an interdisciplinary team approach involving infectious diseases, urology, and antimicrobial stewardship for complex UTI management.
  • Standardize diagnosis using anatomic and symptom-based criteria to differentiate infectious from noninfectious urinary syndromes.
  • Avoid reliance on nonspecific symptoms for UTI diagnosis to reduce unnecessary antibiotic use.
  • Incorporate antimicrobial stewardship pharmacists to optimize antibiotic selection and dosing, especially for multidrug-resistant infections.
  • Evaluate for and address urologic sources of bacterial persistence to improve infection control.
  • Implement prevention strategies for recurrent UTIs and monitor effectiveness longitudinally.

References

Original Source(s)

Related Content